Skip to main content

Table 1 Multivariate analysis of variance correlating CBX2 and clinicopathological features in primary PCa from MSKCC cohort

From: Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

Factor

F value

p value

Significance

Age

4.8235

0.030674

*

Extension

1.9261

0.131084

 

Gleason

5.5086

0.021142

*

Nodal

15.4775

0.000165

***

Race

0.7067

0.55053

 

Sem Vesicle

0.0262

0.871665

 

SurgMargins

0.0839

0.772712

 

T stage

0.5005

0.607944

 
  1. FDR false discovery rate
  2. ***p ≤ 0.001; *p ≤ 0.05